Envisagenics

Biomedical data might hold the key to finding the cure for currently incurable diseases. Our mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development. Our Software as a service (SaaS) to extract biologically relevant RNA isoforms from raw RNA-seq data. Discover new drug targets and biomarkers through splice isoform quantification coupled with predictive-analytics. Prioritize disease-related genes connecting your data to our databases and algorithms. Rapidly advance to experimental validation with a well supported list of targets.
Company Growth (employees)
Type
Private
HQ
Huntington, US
Founded
2014
Size (employees)
7 (est)+17%
Envisagenics was founded in 2014 and is headquartered in Huntington, US

Envisagenics Office Locations

Envisagenics has an office in Huntington

Envisagenics Data and Metrics

Summary Metrics

Founding Date

2014

Total Funding

$225 k

Latest funding size

$225 k

Time since last funding

about 2 years

Investors

Envisagenics's latest funding round in August 2015 was reported to be $225 k. In total, Envisagenics has raised $225 k

Traffic Overview of Envisagenics

Envisagenics Online and Social Media Presence

Envisagenics Company Life and Culture

You may also be interested in